Coagulopathy and Extremely Elevated PT/INR after Dabigatran Etexilate Use in a Patient with End-Stage Renal Disease

Introduction. Dabigatran is an oral direct thrombin inhibitor which has been approved for prophylaxis of stroke in patients with atrial fibrillation. The use of dabigatran etexilate increased rapidly due to many benefits. However, questions have been raised constantly regarding the safety of dabigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joonseok, Yadava, Mrinal, An, In Chul, Sayeed, Abrar, Laird-Fick, Heather S., Gourineni, Venu, Abela, George S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789314/
https://www.ncbi.nlm.nih.gov/pubmed/24151507
http://dx.doi.org/10.1155/2013/131395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789314/
https://www.ncbi.nlm.nih.gov/pubmed/24151507
http://dx.doi.org/10.1155/2013/131395

Ejemplares similares